Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

Authors

Barbara Drobits, Medical University of Vienna
Martin Holcmann, Medical University of Vienna
Nicole Amberg, Medical University of Vienna
Melissa Swiecki, Washington University School of Medicine in St. Louis
Roland Grundtner, Medical University of Vienna
Martina Hammer, Medical University of Vienna
Marco Colonna, Washington University School of Medicine in St. LouisFollow
Maria Sibilia, Medical University of Vienna

Journal

The Journal of Clinical Investigation

Publication Date

2012

Volume

122

Issue

2

Inclusive Pages

575-585

Document Type

Open Access Publication

DOI

10.1172/JCI61034

Rights and Permissions

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells Barbara Drobits, Martin Holcmann, Nicole Amberg, Melissa Swiecki, Roland Grundtner, Martina Hammer, Marco Colonna, Maria Sibilia Published in Volume 122, Issue 2 J Clin Invest. 2012; 122(2):575–585 doi:10.1172/JCI61034

Recommended Citation

Drobits, Barbara; Holcmann, Martin; Amberg, Nicole; Swiecki, Melissa; Grundtner, Roland; Hammer, Martina; Colonna, Marco; and Sibilia, Maria, "Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells." The Journal of Clinical Investigation. 122, 2. 575-585. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/1688